Search research articles
Contact Us
Filters
Showing results (191-200 of 268) with videos related to
Page
of 27
Sort By:
Neoplasia (New York, N.Y.)
|
November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancer
Theodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Frontiers in Oncology
|
April 17, 2025
Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer
Anna R Schreiber, Stephen G Smoots, Marilyn M Jackson, et al.
Journal of Visualized Experiments : Jove
|
January 2, 2023
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Jordi M Lanis, Matthew S Lewis, Hannah Strassburger, et al.
Endocrine-Related Cancer
|
July 21, 2019
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC
Adwitiya Kar, Yu Zhang, Betelehem W Yacob, et al.
Journal of Visualized Experiments : Jove
|
October 22, 2016
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Stacey Bagby, Wells A Messersmith, Todd M Pitts, et al.
Kidney International
|
February 8, 2025
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model
Sarah C Asby, Lauren E Thompson, Michael Goedken, et al.
Immunology and Cell Biology
|
August 26, 2015
TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes
Divya Ramnath, Kathryn Tunny, Daniel M Hohenhaus, et al.
The Oncologist
|
August 25, 2018
A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer
S Lindsey Davis, S Gail Eckhardt, Jennifer R Diamond, et al.
Journal of Molecular Biology
|
June 23, 2018
Biliverdin Reductase B Dynamics Are Coupled to Coenzyme Binding
Natasia Paukovich, Mengjun Xue, James R Elder, et al.
Molecular Oncology
|
April 24, 2012
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
John J Arcaroli, Rebecca W Powell, Marileila Varella-Garcia, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 268) with videos related to
Sort By:
Page
of 27
Neoplasia (New York, N.Y.)
|
November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancer
Theodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
Frontiers in Oncology
|
April 17, 2025
Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer
Anna R Schreiber, Stephen G Smoots, Marilyn M Jackson, et al.
Journal of Visualized Experiments : Jove
|
January 2, 2023
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Jordi M Lanis, Matthew S Lewis, Hannah Strassburger, et al.
Endocrine-Related Cancer
|
July 21, 2019
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC
Adwitiya Kar, Yu Zhang, Betelehem W Yacob, et al.
Journal of Visualized Experiments : Jove
|
October 22, 2016
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Stacey Bagby, Wells A Messersmith, Todd M Pitts, et al.
Kidney International
|
February 8, 2025
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model
Sarah C Asby, Lauren E Thompson, Michael Goedken, et al.
Immunology and Cell Biology
|
August 26, 2015
TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes
Divya Ramnath, Kathryn Tunny, Daniel M Hohenhaus, et al.
The Oncologist
|
August 25, 2018
A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer
S Lindsey Davis, S Gail Eckhardt, Jennifer R Diamond, et al.
Journal of Molecular Biology
|
June 23, 2018
Biliverdin Reductase B Dynamics Are Coupled to Coenzyme Binding
Natasia Paukovich, Mengjun Xue, James R Elder, et al.
Molecular Oncology
|
April 24, 2012
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
John J Arcaroli, Rebecca W Powell, Marileila Varella-Garcia, et al.
Page
of 27